US Stock MarketDetailed Quotes

Neumora Therapeutics (NMRA)

Watchlist
  • 2.130
  • -0.020-0.93%
Close Jan 15 16:00 ET
  • 2.060
  • -0.070-3.28%
Post 20:01 ET
361.97MMarket Cap-1.45P/E (TTM)

Neumora Therapeutics (NMRA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-39.27%-46.63M
6.68%-52.4M
-38.40%-59.45M
-12.04%-182.94M
2.14%-50.34M
29.91%-33.48M
-81.03%-56.16M
-30.01%-42.96M
-42.11%-163.28M
-69.41%-51.44M
Net income from continuing operations
21.77%-56.76M
10.17%-52.73M
-26.57%-67.99M
-3.33%-243.79M
45.90%-58.82M
-36.81%-72.55M
-52.30%-58.7M
-50.80%-53.72M
-80.23%-235.93M
-286.31%-108.73M
Depreciation and amortization
-85.26%23K
-88.13%19K
-0.63%157K
-5.54%631K
-5.42%157K
-9.83%156K
-6.43%160K
0.00%158K
12.46%668K
12.93%166K
Other non cash items
-63.70%310K
48.15%1.2M
10.87%877K
-95.08%3.31M
-98.68%856K
-0.58%854K
-4.47%812K
-2.83%791K
339.50%67.38M
8,204.23%64.86M
Change In working capital
-84.77%4.48M
15.82%-7.6M
-114.62%-525K
354.37%22.64M
89.66%-1.36M
2,567.23%29.43M
-277.22%-9.03M
1,062.14%3.59M
-28.08%-8.9M
-153.27%-13.11M
-Change in prepaid assets
-101.84%-326K
101.49%145K
-86.86%966K
239.51%15.91M
107.37%599K
356.79%17.69M
-129.56%-9.74M
-6.45%7.35M
-214.25%-11.4M
-293.18%-8.13M
-Change in payables and accrued expense
-62.16%4.77M
-541.19%-6.74M
80.53%-576K
71.19%10.11M
73.92%-1.06M
91.93%12.6M
-84.97%1.53M
56.16%-2.96M
305.96%5.91M
-203.85%-4.07M
-Change in other current assets
--1K
----
----
--0
--0
--0
----
----
--0
----
-Change in other current liabilities
104.53%39K
-16.55%-958K
-14.09%-915K
0.73%-3.38M
2.19%-893K
0.92%-861K
-0.24%-822K
-0.12%-802K
-86.36%-3.4M
-16.90%-913K
Cash from discontinued investing activities
Operating cash flow
-39.27%-46.63M
6.68%-52.4M
-38.40%-59.45M
-12.04%-182.94M
2.14%-50.34M
29.91%-33.48M
-81.03%-56.16M
-30.01%-42.96M
-42.11%-163.28M
-69.41%-51.44M
Investing cash flow
Cash flow from continuing investing activities
-67.31%51.32M
43.01%30.4M
129.44%44.16M
-209.58%-70.56M
-822.37%-98.8M
559.20%156.99M
-11.72%21.26M
-5,424.85%-150M
138.32%64.39M
270.32%13.68M
Net PPE purchase and sale
--71K
----
----
--0
--0
--0
--0
--0
77.10%-117K
-91.30%-44K
Net investment purchase and sale
-67.36%51.25M
42.62%30.31M
129.59%44.16M
-201.00%-69.78M
-639.56%-98.8M
558.18%156.99M
-11.72%21.26M
-5,330.49%-149.23M
144.72%69.09M
328.69%18.31M
Net other investing changes
----
----
----
83.12%-775K
--0
--0
--0
---775K
64.69%-4.59M
----
Cash from discontinued investing activities
Investing cash flow
-67.31%51.32M
43.01%30.4M
129.44%44.16M
-209.58%-70.56M
-822.37%-98.8M
559.20%156.99M
-11.72%21.26M
-5,424.85%-150M
138.32%64.39M
270.32%13.68M
Financing cash flow
Cash flow from continuing financing activities
-108.88%-136K
595.44%18.46M
0
-90.69%21.6M
3,337.63%15.57M
-99.34%1.53M
808.90%2.65M
1,726.73%1.85M
100.39%231.94M
-101.79%-481K
Net issuance payments of debt
---136K
----
----
----
----
--0
----
----
----
----
Net common stock issuance
----
----
----
-94.12%13.69M
2,934.83%13.92M
----
----
----
--232.88M
---491K
Net preferred stock issuance
----
----
----
--0
----
----
----
----
--0
----
Proceeds from stock option exercised by employees
--0
-97.78%59K
--0
176.93%7.91M
99.28%1.65M
16.21%1.76M
556.93%2.65M
1,562.16%1.85M
-33.13%2.86M
-49.85%830K
Net other financing activities
----
----
----
----
----
----
----
----
-411.29%-3.8M
-498.06%-820K
Cash from discontinued financing activities
Financing cash flow
-108.88%-136K
595.44%18.46M
--0
-90.69%21.6M
3,337.63%15.57M
-99.34%1.53M
808.90%2.65M
1,726.73%1.85M
100.39%231.94M
-101.79%-481K
Net cash flow
Beginning cash position
-18.02%124.52M
-30.45%128.07M
-61.80%143.36M
54.93%375.25M
-33.03%276.93M
-26.06%151.89M
-13.18%184.14M
54.93%375.25M
-40.83%242.21M
62.94%413.5M
Current changes in cash
-96.36%4.55M
88.99%-3.55M
92.00%-15.29M
-274.29%-231.89M
-249.23%-133.57M
-39.91%125.04M
-384.80%-32.25M
-534.44%-191.11M
179.59%133.05M
-230.76%-38.25M
End cash Position
-53.39%129.07M
-18.02%124.52M
-30.45%128.07M
-61.80%143.36M
-61.80%143.36M
-33.03%276.93M
-26.06%151.89M
-13.18%184.14M
54.93%375.25M
54.93%375.25M
Free cash flow
-39.32%-46.65M
6.68%-52.4M
-38.40%-59.45M
-11.96%-182.94M
2.23%-50.34M
29.97%-33.48M
-81.03%-56.16M
-29.86%-42.96M
-41.58%-163.4M
-69.42%-51.49M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -39.27%-46.63M6.68%-52.4M-38.40%-59.45M-12.04%-182.94M2.14%-50.34M29.91%-33.48M-81.03%-56.16M-30.01%-42.96M-42.11%-163.28M-69.41%-51.44M
Net income from continuing operations 21.77%-56.76M10.17%-52.73M-26.57%-67.99M-3.33%-243.79M45.90%-58.82M-36.81%-72.55M-52.30%-58.7M-50.80%-53.72M-80.23%-235.93M-286.31%-108.73M
Depreciation and amortization -85.26%23K-88.13%19K-0.63%157K-5.54%631K-5.42%157K-9.83%156K-6.43%160K0.00%158K12.46%668K12.93%166K
Other non cash items -63.70%310K48.15%1.2M10.87%877K-95.08%3.31M-98.68%856K-0.58%854K-4.47%812K-2.83%791K339.50%67.38M8,204.23%64.86M
Change In working capital -84.77%4.48M15.82%-7.6M-114.62%-525K354.37%22.64M89.66%-1.36M2,567.23%29.43M-277.22%-9.03M1,062.14%3.59M-28.08%-8.9M-153.27%-13.11M
-Change in prepaid assets -101.84%-326K101.49%145K-86.86%966K239.51%15.91M107.37%599K356.79%17.69M-129.56%-9.74M-6.45%7.35M-214.25%-11.4M-293.18%-8.13M
-Change in payables and accrued expense -62.16%4.77M-541.19%-6.74M80.53%-576K71.19%10.11M73.92%-1.06M91.93%12.6M-84.97%1.53M56.16%-2.96M305.96%5.91M-203.85%-4.07M
-Change in other current assets --1K----------0--0--0----------0----
-Change in other current liabilities 104.53%39K-16.55%-958K-14.09%-915K0.73%-3.38M2.19%-893K0.92%-861K-0.24%-822K-0.12%-802K-86.36%-3.4M-16.90%-913K
Cash from discontinued investing activities
Operating cash flow -39.27%-46.63M6.68%-52.4M-38.40%-59.45M-12.04%-182.94M2.14%-50.34M29.91%-33.48M-81.03%-56.16M-30.01%-42.96M-42.11%-163.28M-69.41%-51.44M
Investing cash flow
Cash flow from continuing investing activities -67.31%51.32M43.01%30.4M129.44%44.16M-209.58%-70.56M-822.37%-98.8M559.20%156.99M-11.72%21.26M-5,424.85%-150M138.32%64.39M270.32%13.68M
Net PPE purchase and sale --71K----------0--0--0--0--077.10%-117K-91.30%-44K
Net investment purchase and sale -67.36%51.25M42.62%30.31M129.59%44.16M-201.00%-69.78M-639.56%-98.8M558.18%156.99M-11.72%21.26M-5,330.49%-149.23M144.72%69.09M328.69%18.31M
Net other investing changes ------------83.12%-775K--0--0--0---775K64.69%-4.59M----
Cash from discontinued investing activities
Investing cash flow -67.31%51.32M43.01%30.4M129.44%44.16M-209.58%-70.56M-822.37%-98.8M559.20%156.99M-11.72%21.26M-5,424.85%-150M138.32%64.39M270.32%13.68M
Financing cash flow
Cash flow from continuing financing activities -108.88%-136K595.44%18.46M0-90.69%21.6M3,337.63%15.57M-99.34%1.53M808.90%2.65M1,726.73%1.85M100.39%231.94M-101.79%-481K
Net issuance payments of debt ---136K------------------0----------------
Net common stock issuance -------------94.12%13.69M2,934.83%13.92M--------------232.88M---491K
Net preferred stock issuance --------------0------------------0----
Proceeds from stock option exercised by employees --0-97.78%59K--0176.93%7.91M99.28%1.65M16.21%1.76M556.93%2.65M1,562.16%1.85M-33.13%2.86M-49.85%830K
Net other financing activities ---------------------------------411.29%-3.8M-498.06%-820K
Cash from discontinued financing activities
Financing cash flow -108.88%-136K595.44%18.46M--0-90.69%21.6M3,337.63%15.57M-99.34%1.53M808.90%2.65M1,726.73%1.85M100.39%231.94M-101.79%-481K
Net cash flow
Beginning cash position -18.02%124.52M-30.45%128.07M-61.80%143.36M54.93%375.25M-33.03%276.93M-26.06%151.89M-13.18%184.14M54.93%375.25M-40.83%242.21M62.94%413.5M
Current changes in cash -96.36%4.55M88.99%-3.55M92.00%-15.29M-274.29%-231.89M-249.23%-133.57M-39.91%125.04M-384.80%-32.25M-534.44%-191.11M179.59%133.05M-230.76%-38.25M
End cash Position -53.39%129.07M-18.02%124.52M-30.45%128.07M-61.80%143.36M-61.80%143.36M-33.03%276.93M-26.06%151.89M-13.18%184.14M54.93%375.25M54.93%375.25M
Free cash flow -39.32%-46.65M6.68%-52.4M-38.40%-59.45M-11.96%-182.94M2.23%-50.34M29.97%-33.48M-81.03%-56.16M-29.86%-42.96M-41.58%-163.4M-69.42%-51.49M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More